| 1 |
Gomez SL, Von Behren J, Mckinley M, et al. Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes [J]. Breast Cancer Res Treat, 2017, 164(1):139-147.
|
| 2 |
Desantis CE, Fedewa SA, Goding SA, et al. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women [J]. CA Cancer J Clin, 2016, 66(1):31-42.
|
| 3 |
Torre LA, Sauer AM, Chen MJ, et al. Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females [J]. CA Cancer J Clin, 2016, 66(3):182-202.
|
| 4 |
赵丽，周晓东，于铭, 等. 超声及超声造影技术对乳腺癌新辅助化疗的疗效评价 [J]. 中国超声医学杂志, 2010, 26(8):702-704.
|
| 5 |
周如海，邬颖杰，吴猛, 等. 超声造影技术在乳腺癌新辅助化疗疗效评估中的应用价值 [J]. 医学影像学杂志. 2015, 25(4):711-714.
|
| 6 |
杨晓婧，王法，娜迪热·铁列吾汗. 超声造影在乳腺癌新辅助化疗疗效评价中的价值 [J]. 中华实用诊断与治疗杂志, 2016, 30(4):396-398.
|
| 7 |
Wang JW, Cao LH, Han F, et al. Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy [J]. Acta Radiol, 2013, 54(8):882-888.
|
| 8 |
Wang JW, Zheng W, Liu JB, et al. Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts [J]. PLoS One, 2013, 8(3):e58274.
|
| 9 |
Bosch AM, Kessels AG, Beets GL, et al. Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours [J]. Eur J Radiol, 2003, 48(3):285-292.
|
| 10 |
Zhou JH, Cao LH, Liu JB, et al. Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US [J]. Radiology, 2011, 259(2):406-413.
|
| 11 |
金亚，马步云，彭玉兰, 等. 多参数超声评估乳腺癌新辅助化疗疗效的价值 [J]. 中国超声医学杂志, 2014, 30(12):1083-1085.
|
| 12 |
Jia WR, Tang L, Wang DB, et al. Three-dimensional Contrast-enhanced Ultrasound in Response Assessment for Breast Cancer: A Comparison with Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathology [J]. Sci Rep, 2016, 6:33832.
|
| 13 |
Hoyt K, Umphrey H, Lockhart M, et al. Ultrasound imaging of breast tumor perfusion and neovascular morphology [J]. Ultrasound Med Biol, 2015, 41(9):2292-2302.
|
| 14 |
Amioka A, Masumoto N, Gouda N, et al. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy [J]. Jpn J Clin Oncol, 2016, 46(4):303-309.
|
| 15 |
Lavisse S, Lejeune P, Rouffiac V, et al. Early quantitative evaluation of a tumor vasculature disruptive agent AVE8062 using dynamic contrast-enhanced ultrasonography [J]. Invest Radiol, 2008, 43(2):100-111.
|
| 16 |
Emoto M, Tachibana K, Iwasaki H, et al. Antitumor effect of TNP-470, an angiogenesis inhibitor, combined with ultrasound irradiation for human uterine sarcoma xenografts evaluated using contrast color Doppler ultrasound [J]. Cancer Sci, 2007, 98(6):929-935.
|
| 17 |
Escudier B, Lassau N, Angevin E, et al. Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma [J]. Clin Cancer Res, 2007, 13(6):1801-1809.
|
| 18 |
Pollard RE, Broumas AR, Wisner ER, et al. Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats [J]. Ultrasound Med Biol, 2007, 33(2):235-245.
|
| 19 |
张萌璐，马步云. 乳腺癌新辅助化疗前后超声造影表现 [J]. 中国介入影像与治疗学, 2015, 12(1):52-55.
|
| 20 |
张林，郝洁，王立平, 等. 乳腺超声造影、彩色多普勒超声及磁共振灌注成像在评估乳腺癌新辅助化疗疗效中的对比研究 [J]. 华中科技大学学报(医学版), 2014, 43(4):449-452.
|
| 21 |
郭莉，郝轶，张银华, 等. 超声造影对评估乳腺癌原发灶新辅助化疗疗效的价值 [J]. 新疆医科大学学报, 2015, 38(12):1553-1555.
|
| 22 |
耿怡，马富成，热西达·加帕尔, 等. 双模态超声在评估乳腺癌新辅助化疗疗效中的应用价值 [J]. 新疆医科大学学报, 2017, 40(3):275-278.
|
| 23 |
胡向东，刘玉江，谭小蕖, 等. 超声造影预测乳腺癌新辅助化疗疗效分析 [J]. 临床和实验医学杂志, 2014, 13(21):1770-1773.
|
| 24 |
Cao X, Xue J, Zhao B. Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer [J]. Ultrasound Med Biol, 2012, 38(12):2065-2071.
|
| 25 |
Mori N, Mugikura S, Takahashi S, et al. Quantitative Analysis of Contrast-Enhanced Ultrasound Imaging in Invasive Breast Cancer: A Novel Technique to Obtain Histopathologic Information of Microvessel Density [J]. Ultrasound Med Biol, 2017, 43(3):607-614.
|
| 26 |
Saracco A, Szabo BK, Tanczos E, et al. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy [J]. Acta Radiol, 2017, 58(4):394-402.
|
| 27 |
Zhou SC, Le J, Fan YW, et al. Study on breast cancer animal model of tumor-micro vessel variation before and after the chemotherapy by contrast enhanced ultrasound quantitative analysis [J]. Pak J Pharm Sci, 2016, 29(4):1407-1413.
|
| 28 |
Wang JW, Zheng W, Chen Y, et al. Quantitative assessment of tumor blood flow changes in a murine breast cancer model after adriamycin chemotherapy using contrast-enhanced destruction-replenishment sonography [J]. J Ultrasound Med, 2013, 32(4):683-690.
|
| 29 |
Prevos R, Smidt ML, Tjan-Heijnen VC, et al. Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review [J]. Eur Radiol, 2012, 22(12):2607-2616.
|
| 30 |
Belli P, Costantini M, Malaspina C, et al. MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy [J]. Clin Radiol, 2006, 61(11):946-953.
|
| 31 |
Zhu AX, Holalkere NS, Muzikansky A, et al. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma [J]. Oncologist, 2008, 13(2):120-125.
|
| 32 |
Fukuda T, Horii R, Gomi N, et al. Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype [J]. Springerplus, 2016, 5:152.
|
| 33 |
Marinovich ML, Houssami N, Macaskill P, et al. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy [J]. J Natl Cancer Inst, 2013, 105(5):321-333.
|
| 34 |
Wu LM, Hu JN, Gu HY, et al. Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer? [J]. Breast Cancer Res Treat, 2012, 135(1):17-28.
|
| 35 |
Balleyguier C, Opolon P, Mathieu MC, et al. New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature [J]. Eur J Radiol. 2009, 69(1):14-23.
|
| 36 |
Guibal A, Taillade L, Mule S, et al. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy [J]. Radiology, 2010, 254(2):420-429.
|